SAT-564 Effectiveness of Treatment with Mineralocorticoid Receptor Antagonistsin Primary Aldosteronism

Background: Medical treatment with mineralocorticoid receptor antagonists (MRAs) is preferred for patients with primary aldosteronism (PA) who are not surgical candidates. Adequate mineralocorticoid receptor blockade, as suggested by renin elevation above suppression levels, has been associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Tezuka, Yuta, Turcu, Adina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207393/
http://dx.doi.org/10.1210/jendso/bvaa046.1399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207393/
http://dx.doi.org/10.1210/jendso/bvaa046.1399

Ejemplares similares